CA 242 in Pancreatic Lesions
Author Information
Author(s): C. Haglund, J. Lindgren, P.J. Roberts, P. Kuusela, S. Nordling
Primary Institution: Helsinki University Central Hospital; University of Helsinki
Hypothesis
The study investigates the expression of the tumor-associated antigen CA 242 in pancreatic lesions and its potential as a serum tumor marker.
Conclusion
CA 242 is expressed in most pancreatic carcinomas and may serve as a potential serum tumor marker.
Supporting Evidence
- 93% of well to moderately differentiated ductal adenocarcinomas expressed CA 242.
- CA 242 was found in 91% of chronic pancreatitis specimens.
- 65% of pancreatic cancer patients had elevated serum CA 242 levels.
Takeaway
The study found that a special marker called CA 242 is found in many pancreatic cancers, which could help doctors find and treat these cancers better.
Methodology
The study used immunoperoxidase staining on formalin-fixed, paraffin-embedded tissue sections from various pancreatic lesions.
Limitations
The study does not establish a clear correlation between tissue expression and serum levels of CA 242.
Want to read the original?
Access the complete publication on the publisher's website